Clinical Performance Measures for Emergency Department Care for Adults With Intracranial Hemorrhage.

[1]  J. Mocco,et al.  2022 Guideline for the Management of Patients With Spontaneous Intracerebral Hemorrhage: A Guideline From the American Heart Association/American Stroke Association. , 2022, Stroke.

[2]  A. Janke,et al.  National trends in emergency department closures, mergers, and utilization, 2005-2015 , 2021, PloS one.

[3]  A. Demchuk,et al.  Hemostatic Efficacy and Anti-FXa (Factor Xa) Reversal With Andexanet Alfa in Intracranial Hemorrhage , 2021, Stroke.

[4]  O. Sadan,et al.  Aneurysmal Subarachnoid Hemorrhage: Trends, Outcomes, and Predictions From a 15-Year Perspective of a Single Neurocritical Care Unit , 2020, Neurosurgery.

[5]  E. Finn,et al.  A Multimodal Intervention to Improve the Quality and Safety of Interhospital Care Transitions for Nontraumatic Intracerebral and Subarachnoid Hemorrhage. , 2020, Joint Commission journal on quality and patient safety.

[6]  A. Charidimou,et al.  Noncontrast CT markers of intracerebral hemorrhage expansion and poor outcome , 2020, Neurology.

[7]  K. Derry,et al.  Treatment of adults with intracranial hemorrhage on apixaban or rivaroxaban with prothrombin complex concentrate products , 2020, Journal of Thrombosis and Thrombolysis.

[8]  J. Goldstein,et al.  Ultra‐Early Blood Pressure Reduction Attenuates Hematoma Growth and Improves Outcome in Intracerebral Hemorrhage , 2020, Annals of neurology.

[9]  G. Brophy,et al.  Factor Xa Inhibitor-Related Intracranial Hemorrhage , 2020, Circulation.

[10]  K. Colton,et al.  Early Stroke Recognition and Time-based Emergency Care Performance Metrics for Intracerebral Hemorrhage. , 2019, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[11]  L. Schwamm,et al.  Resource utilisation among patients transferred for intracerebral haemorrhage , 2019, Stroke & Vascular Neurology.

[12]  W. Wright,et al.  Clinical Performance Measures for Neurocritical Care: A Statement for Healthcare Professionals from the Neurocritical Care Society , 2019, Neurocritical care.

[13]  C. Anderson,et al.  Blood pressure control and clinical outcomes in acute intracerebral haemorrhage: a preplanned pooled analysis of individual participant data , 2019, The Lancet Neurology.

[14]  Lai,et al.  Meta-Analysis of Accuracy of the Spot Sign for Predicting Hematoma Growth and Clinical Outcomes. , 2019, Stroke.

[15]  C. Matouk,et al.  A Qualitative Study of Risks Related to Interhospital Transfer of Patients with Nontraumatic Intracranial Hemorrhage. , 2019, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[16]  A. Demchuk,et al.  Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors , 2019, The New England journal of medicine.

[17]  A. Sweidan,et al.  Contemporary Reversal of Oral Anticoagulation in Intracerebral Hemorrhage , 2019, Stroke.

[18]  H. Schünemann,et al.  Management of direct factor Xa inhibitor-related major bleeding with prothrombin complex concentrate: a meta-analysis. , 2019, Blood advances.

[19]  A. J. Roberts,et al.  Effect of low and moderate dose FEIBA to reverse major bleeding in patients on direct oral anticoagulants. , 2019, Thrombosis research.

[20]  Y. Fujii,et al.  Absolute risk and predictors of the growth of acute spontaneous intracerebral haemorrhage: a systematic review and meta-analysis of individual patient data , 2018 .

[21]  Bainan Xu,et al.  Accuracy of spot sign in predicting hematoma expansion and clinical outcome , 2018, Medicine.

[22]  D. Heyland,et al.  Outcomes and Costs of Patients Admitted to the ICU Due to Spontaneous Intracranial Hemorrhage , 2018, Critical care medicine.

[23]  Mary G. George,et al.  Clinical Performance Measures for Adults Hospitalized With Intracerebral Hemorrhage: Performance Measures for Healthcare Professionals From the American Heart Association/American Stroke Association , 2014, Stroke.

[24]  Zhenxing Li,et al.  Effects of Intensive Blood Pressure Reduction on Acute Intracerebral Hemorrhage: A Systematic Review and Meta-analysis , 2017, Scientific Reports.

[25]  T. Steiner,et al.  Idarucizumab for Dabigatran Reversal — Full Cohort Analysis , 2017, The New England journal of medicine.

[26]  L. Schwamm,et al.  The American Heart Association’s Get With the Guidelines (GWTG)-Stroke development and impact on stroke care , 2017, Stroke and Vascular Neurology.

[27]  B. Ritchie,et al.  Reversal of dabigatran-associated major bleeding with activated prothrombin concentrate: A prospective cohort study. , 2017, Thrombosis research.

[28]  M. Silvestrini,et al.  How Should We Lower Blood Pressure after Cerebral Hemorrhage? A Systematic Review and Meta-Analysis , 2017, Cerebrovascular Diseases.

[29]  A. Charidimou,et al.  Intensive blood pressure lowering in patients with acute intracerebral haemorrhage: clinical outcomes and haemorrhage expansion. Systematic review and meta-analysis of randomised trials , 2017, Journal of Neurology, Neurosurgery, and Psychiatry.

[30]  R. Bellomo,et al.  Subarachnoid Hemorrhage Patients Admitted to Intensive Care in Australia and New Zealand: A Multicenter Cohort Analysis of In-Hospital Mortality Over 15 Years , 2017, Critical care medicine.

[31]  Rustam Al-Shahi Salman,et al.  Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial , 2016, The Lancet.

[32]  D. Hanley,et al.  Intensive Blood-Pressure Lowering in Patients with Acute Cerebral Hemorrhage. , 2016, The New England journal of medicine.

[33]  P. Bath,et al.  Blood pressure management in acute stroke , 2016, Stroke and Vascular Neurology.

[34]  W. Hacke,et al.  Fresh frozen plasma versus prothrombin complex concentrate in patients with intracranial haemorrhage related to vitamin K antagonists (INCH): a randomised trial , 2016, The Lancet Neurology.

[35]  Na Li,et al.  Predicting Intracerebral Hemorrhage Growth With the Spot Sign: The Effect of Onset-to-Scan Time , 2016, Stroke.

[36]  C. Anderson,et al.  Guidelines for the Management of Spontaneous Intracerebral Hemorrhage: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association , 2015, Stroke.

[37]  M. Woodward,et al.  Magnitude of blood pressure reduction and clinical outcomes in acute intracerebral hemorrhage: intensive blood pressure reduction in acute cerebral hemorrhage trial study. , 2015, Hypertension.

[38]  M. Woodward,et al.  Rapid Blood Pressure Lowering According to Recovery at Different Time Intervals after Acute Intracerebral Hemorrhage: Pooled Analysis of the INTERACT Studies , 2015, Cerebrovascular Diseases.

[39]  T. Beasley,et al.  Prolonged Emergency Department Length of Stay as a Predictor of Adverse Outcomes in Patients with Intracranial Hemorrhage , 2015, Journal of critical care medicine.

[40]  Eric E. Smith,et al.  Door-to-needle times for tissue plasminogen activator administration and clinical outcomes in acute ischemic stroke before and after a quality improvement initiative. , 2014, JAMA.

[41]  M. Woodward,et al.  Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. , 2013, The New England journal of medicine.

[42]  B. Norrving,et al.  Long term (13 years) prognosis after primary intracerebral haemorrhage: a prospective population based study of long term mortality, prognostic factors and causes of death , 2013, Journal of Neurology, Neurosurgery & Psychiatry.

[43]  A. Demchuk,et al.  The Intracerebral Hemorrhage Acutely Decreasing Arterial Pressure Trial , 2013, Stroke.

[44]  R. Tamargo,et al.  Impact of pattern of admission on outcomes after aneurysmal subarachnoid hemorrhage. , 2012, Journal of critical care.

[45]  D. Drazin,et al.  The Effect of Transfer and Hospital Volume in Subarachnoid Hemorrhage Patients , 2012, Neurocritical Care.

[46]  Adrian F Hernandez,et al.  Comparison of 30-day mortality models for profiling hospital performance in acute ischemic stroke with vs without adjustment for stroke severity. , 2012, JAMA.

[47]  Paul Vespa,et al.  Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association , 2012, Stroke.

[48]  A. Demchuk,et al.  Prediction of haematoma growth and outcome in patients with intracerebral haemorrhage using the CT-angiography spot sign (PREDICT): a prospective observational study , 2012, The Lancet Neurology.

[49]  Derek C Angus,et al.  Reorganizing adult critical care delivery: the role of regionalization, telemedicine, and community outreach. , 2010, American journal of respiratory and critical care medicine.

[50]  Mitchell S. V. Elkind,et al.  Impact of Delayed Transfer of Critically Ill Stroke Patients from the Emergency Department to the Neuro-ICU , 2010, Neurocritical care.

[51]  M. Hartmann,et al.  Hematoma Growth and Outcome in Treated Neurocritical Care Patients With Intracerebral Hemorrhage Related to Oral Anticoagulant Therapy: Comparison of Acute Treatment Strategies Using Vitamin K, Fresh Frozen Plasma, and Prothrombin Complex Concentrates , 2006, Stroke.

[52]  S M Davis,et al.  Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage , 2006, Neurology.

[53]  W. Ageno,et al.  Management of coumarin-associated coagulopathy in the non-bleeding patient: a systematic review. , 2004, Haematologica.

[54]  H. Naritomi,et al.  Correction of INR by prothrombin complex concentrate and vitamin K in patients with warfarin related hemorrhagic complication. , 2002, Thrombosis research.

[55]  W R Clarke,et al.  Baseline NIH Stroke Scale score strongly predicts outcome after stroke , 1999, Neurology.